Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C
The results of antiviral therapy for hepatitis C virus (HCV) have improved recently with the use of pegylated interferon (PEG-IFN)/ribavirin (RBV) combination therapy. At this point, most patients with chronic HCV remain untreated. Thus, it is anticipated that therapy will be more appealing and pres...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2006-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2006/357259 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554168140693504 |
|---|---|
| author | CG Nudo P Wong N Hilzenrat M Deschênes |
| author_facet | CG Nudo P Wong N Hilzenrat M Deschênes |
| author_sort | CG Nudo |
| collection | DOAJ |
| description | The results of antiviral therapy for hepatitis C virus (HCV) have improved recently with the use of pegylated interferon (PEG-IFN)/ribavirin (RBV) combination therapy. At this point, most patients with chronic HCV remain untreated. Thus, it is anticipated that therapy will be more appealing and prescribed more broadly than in the past, including in patients considered marginal. |
| format | Article |
| id | doaj-art-a8373cfd3ca64bc4a031318f2b6f1105 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2006-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-a8373cfd3ca64bc4a031318f2b6f11052025-02-03T05:52:18ZengWileyCanadian Journal of Gastroenterology0835-79002006-01-0120958959210.1155/2006/357259Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis CCG Nudo0P Wong1N Hilzenrat2M Deschênes3Department of Medicine, McGill University Health Centre, Montreal, Quebec, CanadaDepartment of Medicine, McGill University Health Centre, Montreal, Quebec, CanadaDepartment of Medicine, McGill University Health Centre, Montreal, Quebec, CanadaDepartment of Medicine, McGill University Health Centre, Montreal, Quebec, CanadaThe results of antiviral therapy for hepatitis C virus (HCV) have improved recently with the use of pegylated interferon (PEG-IFN)/ribavirin (RBV) combination therapy. At this point, most patients with chronic HCV remain untreated. Thus, it is anticipated that therapy will be more appealing and prescribed more broadly than in the past, including in patients considered marginal.http://dx.doi.org/10.1155/2006/357259 |
| spellingShingle | CG Nudo P Wong N Hilzenrat M Deschênes Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C Canadian Journal of Gastroenterology |
| title | Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C |
| title_full | Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C |
| title_fullStr | Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C |
| title_full_unstemmed | Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C |
| title_short | Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C |
| title_sort | elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis c |
| url | http://dx.doi.org/10.1155/2006/357259 |
| work_keys_str_mv | AT cgnudo elderlypatientsareatgreaterriskofcytopeniaduringantiviraltherapyforhepatitisc AT pwong elderlypatientsareatgreaterriskofcytopeniaduringantiviraltherapyforhepatitisc AT nhilzenrat elderlypatientsareatgreaterriskofcytopeniaduringantiviraltherapyforhepatitisc AT mdeschenes elderlypatientsareatgreaterriskofcytopeniaduringantiviraltherapyforhepatitisc |